The Impact of Preoperative Immune Modulating Nutrition on Outcomes in Patients Undergoing Surgery for Gastrointestinal Cancer A Systematic Review and Meta-analysis

被引:202
作者
Adiamah, Alfred [1 ,2 ,3 ]
Skorepa, Pavel [1 ,2 ,3 ,4 ]
Weimann, Arved [5 ]
Lobo, Dileep N. [1 ,2 ,3 ,6 ]
机构
[1] Nottingham Univ Hosp NHS Trust, Nottingham Digest Dis Ctr, Gastrointestinal Surg, Nottingham, England
[2] Nottingham Univ Hosp NHS Trust, NIHR, Biomed Res Ctr, Nottingham, England
[3] Univ Nottingham, Queens Med Ctr, Nottingham, England
[4] Univ Def, Dept Mil Internal Med & Mil Hyg, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic
[5] Klinikum St Georg gGmbH, Klin Allgemein Viszeral & Onkol Chirurg, Leipzig, Germany
[6] Univ Nottingham, MRC ARUK Ctr Musculoskeletal Ageing Res, Queens Med Ctr, Sch Life Sci, Nottingham, England
基金
英国医学研究理事会;
关键词
cancer surgery; gastrointestinal cancer; immune modulating nutrition; infectious complications; postoperative outcomes; preoperative nutrition; ENTERAL IMMUNONUTRITION; POSTOPERATIVE COMPLICATIONS; ORAL SUPPLEMENTATION; COLORECTAL-CANCER; PANCREATIC-CANCER; SURGICAL PATIENTS; DOUBLE-BLIND; METAANALYSIS; TRIAL; RISK;
D O I
10.1097/SLA.0000000000003256
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To define the influence of preoperative immune modulating nutrition (IMN) on postoperative outcomes in patients undergoing surgery for gastrointestinal cancer. Background: Although studies have shown that perioperative IMN may reduce postoperative infectious complications, many of these have included patients with benign and malignant disease, and the optimal timing of such an intervention is not clear. Methods: The Embase, Medline, and Cochrane databases were searched from 2000 to 2018, for prospective randomized controlled trials evaluating preoperative oral or enteral IMN in patients undergoing surgery for gastrointestinal cancer. The primary endpoint was the development of postoperative infectious complications. Secondary endpoints included postoperative noninfectious complications, length of stay, and up to 30-day mortality. The analysis was performed using RevMan v5.3 software. Results: Sixteen studies reporting on 1387 patients (715 IMN group, 672 control group) were included. Six of the included studies reported on a mixed population of patients undergoing all gastrointestinal cancer surgery. Of the remaining, 4 investigated IMN in colorectal cancer surgery, 2 in pancreatic surgery, and another 2 in patients undergoing surgery for gastric cancer. There was 1 study each on liver and esophageal cancer. The formulation of nutrition used in all studies in the treated patients was Impact (Novartis/Nestle), which contains omega-3 fatty acids, arginine, and nucleotides. Preoperative IMN in patients undergoing surgery for gastrointestinal cancer reduced infectious complications [odds ratio (OR) 0.52, 95% confidence interval (CI) 0.38-0.71, P < 0.0001, I-2 = 16%, n = 1387] and length of hospital stay (weighted mean difference -1.57 days, 95% CI -2.48 to -0.66, P = 0.0007, I-2 = 34%, n = 995) when compared with control (isocaloric isonitrogeneous feed or normal diet). It, however, did not affect noninfectious complications (OR 0.98, 95% CI 0.73-1.33, P = 0.91, I-2 = 0%, n = 1303) or mortality (OR 0.55, 95% CI 0.18-1.68, P = 0.29, I-2 = 0%, n = 955). Conclusion: Given the significant impact on infectious complications and a tendency to shorten length of stay, preoperative IMN should be encouraged in routine practice in patients undergoing surgery for gastrointestinal cancer.
引用
收藏
页码:247 / 256
页数:10
相关论文
共 53 条
[21]   Measuring inconsistency in meta-analyses [J].
Higgins, JPT ;
Thompson, SG ;
Deeks, JJ ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :557-560
[22]   Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition [J].
Horie, Hisanaga ;
Okada, Masaki ;
Kojima, Masayuki ;
Nagai, Hideo .
SURGERY TODAY, 2006, 36 (12) :1063-1068
[23]   Preoperative immunonutrition in patients at nutritional risk: results of a double-blinded randomized clinical trial [J].
Huebner, M. ;
Cerantola, Y. ;
Grass, F. ;
Bertrand, P. C. ;
Schaefer, M. ;
Demartines, N. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2012, 66 (07) :850-855
[24]   Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials [J].
Kondrup, J ;
Rasmussen, HH ;
Hamberg, O ;
Stanga, Z .
CLINICAL NUTRITION, 2003, 22 (03) :321-336
[25]   Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: A prospective, randomized, controlled, double-blind study [J].
Lobo, Dileep N. ;
Williams, Robert N. ;
Welch, Neil T. ;
Aloysius, Mark M. ;
Nunes, Quentin M. ;
Padmanabhan, Jagannathan ;
Crowe, Janet R. ;
Iftikhar, Syed Y. ;
Parsons, Simon L. ;
Neal, Keith R. ;
Allison, Simon P. ;
Rowlands, Brian J. .
CLINICAL NUTRITION, 2006, 25 (05) :716-726
[26]   A randomized controlled trial of preoperative oral immunonutrition in patients undergoing surgery for colorectal cancer: hospital stay and health care costs [J].
Manzanares Campillo, Maria del Carmen ;
Martin Fernandez, Jesus ;
Amo Salas, Mariano ;
Casanova Rituerto, Daniel .
CIRUGIA Y CIRUJANOS, 2017, 85 (05) :393-400
[27]   A Meta-Analysis of the Effect of Combinations of Immune Modulating Nutrients on Outcome in Patients Undergoing Major Open Gastrointestinal Surgery [J].
Marimuthu, Kanagaraj ;
Varadhan, Krishna K. ;
Ljungqvist, Olle ;
Lobo, Dileep N. .
ANNALS OF SURGERY, 2012, 255 (06) :1060-1068
[28]   Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE) [J].
Martin, R. C. G., II ;
Agle, S. ;
Schlegel, M. ;
Hayat, T. ;
Scoggins, C. R. ;
McMasters, K. M. ;
Philips, P. .
EJSO, 2017, 43 (04) :772-779
[29]   Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: A randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer [J].
Matos de Miranda Torrinhas, Raquel Susana ;
Santana, Raquel ;
Garcia, Thais ;
Cury-Boaventura, Maria Fernanda ;
Sales, Maria Mirtes ;
Curi, Rui ;
Waitzberg, Dan Linetzky .
CLINICAL NUTRITION, 2013, 32 (04) :503-510
[30]   Preoperative oral supplement with immunonutrients in cancer patients [J].
McCarter, MD ;
Gentilini, OD ;
Gomez, ME ;
Daly, JM .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1998, 22 (04) :206-211